Olga Nikolova

The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells

Tamilla Nechiporuk, Stephen E. Kurtz, Olga Nikolova et al. · Cancer Discovery · 2019 · 366 citations · Full text

Medicine, Oncology, Pharmacology +13

Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial

Steve Cunningham, Pedro A. Piedra, Federico Martinón‐Torres et al. · The Lancet Respiratory Medicine · 2020 · 132 citations · Full text

Medicine, Infectious Diseases, Pediatrics +15

CTD2 Dashboard: a searchable web interface to connect validated results from the Cancer Target Discovery and Development Network

Bülent Arman Aksoy, Vlado Dančík, Kenneth Smith et al. · Database · 2017 · 36 citations · Full text

Life Sciences, Bioinformatics, Biomedical Informatics +17

Using interdisciplinary bioinformatics undergraduate research to recruit and retain computer science students

Jon Beck, Brent Buckner, Olga Nikolova · 2007 · 34 citations

Education, Bioinformatics, Computer Science +13

Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer

Chang Xu, Olga Nikolova, Ryan Basom et al. · Clinical Cancer Research · 2018 · 24 citations · Full text

Medicine, Molecular Biology, Oncology +17